Skip to content

Alvotech

US · ALVO #2709 by market cap Listed 2020
4.12 -0.17 -3.96%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 4.25 -0.93%
After-hours 4.12 0.00%
6.153.004.122026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ALVO?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -11.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 1.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall B-

The radar needs all six factors. Available grades are shown below.

Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 19.9x Better than 38%
Price / Sales 3.0x Better than 42%
Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability B

How much profit the business keeps from each dollar of sales and capital.

Gross margin 59.8% Better than 74%
Operating margin 13.3% Better than 61%
Net margin 4.8% Better than 43%
Momentum B-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -7.0% Better than 57%
6-month return 23.4% Better than 85%
12-month return (ex latest month) -6.8% Better than 25%
Distance below 52-week high 36.9% Better than 32%
Financial Health D

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.9x Better than 53%
Debt to assets 97.4% Better than 1%
Interest coverage 2.0x Better than 36%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 94.2% Better than 82%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -1.67%
1M -19.53%
3M -3.51%
6M +24.85%
YTD -19.69%
1Y -18.58%
3Y -54.92%

Key statistics

Price & volume

Prev close
4.29
Open
4.26
Day range
4.09 - 4.29
Avg price
4.17
Volume
826.67K
Turnover
3.45M
Amplitude
4.66%
52-week range
2.94 - 6.53

Valuation

P/E
41.20
P/E (TTM)
-5.02
P/B
-5.50
EPS
0.10
Net profit
35.68M
Net assets
-267.26M

Share structure

Market cap
1.47B
Float cap
498.39M
Shares out
356.82M
Float shares
120.97M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2020-11-09
52-week range 33% of range
2.94 6.53

36.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-3.29M net over the window

Short interest

Shares short
6.18M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Alvotech (ALVO)?

Alvotech last traded at 4.12. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Alvotech's market cap?

About 1.47B.

What is the P/E ratio of Alvotech?

The trailing twelve-month P/E is -5.02, below its own 5-year average of 1.00 — in the middle of its historical range (49.60% percentile). See the Valuation tab for the full history.

Does Alvotech pay a dividend?

Alvotech does not currently pay a regular dividend.

Is Alvotech a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 8.00, which implies 94.2% upside from the current price. This is not investment advice.

What is Alvotech's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Alvotech a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Alvotech discussion 0 comments

Add a comment